Compare Repligen Corporation Common Stock (RGEN) vs Pacer Data & Infra Real Estate ETF (SRVR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Pacer Data & Infra Real Estate ETF — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Pacer Data & Infra Real Estate ETF trades at $27.78 (market cap $300.94M). The key difference: Repligen Corporation Common Stock is far larger — about 37× Pacer Data & Infra Real Estate ETF's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Pacer Data & Infra Real Estate ETF for 16 Days on average.
| RGEN | SRVR | |
|---|---|---|
Market Cap | $11.14B | $300.94M |
Volume | 1,259,263 | 73,849 |
Sector | Health | Sector/Thematic |
52-Week High | $194.57 | $35.74 |
52-Week Low | $102.87 | $27.94 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $11.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
SRVR trades at $28.62, down 1.31% today, with a mixed technical outlook—bullish overall signal but bearish moving averages. Key financial ratios are unavailable, limiting fundamental assessment. Recent news highlights data center ETFs as a way to gain exposure to AI and cloud computing growth, suggesting thematic relevance.
The outlook is cautiously optimistic due to AI-driven demand for data centers, but risks include reliance on thematic trends and lack of current financial data. Investors should seek updated fundamentals to gauge valuation and growth prospects amid competitive and macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Pacer Data & Infra Real Estate ETF
Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →
